Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease

A Mitrofanova, S Merscher, A Fornoni - Nature Reviews Nephrology, 2023 - nature.com
Chronic kidney disease (CKD) is a global health problem with rising incidence and
prevalence. Among several pathogenetic mechanisms responsible for disease progression …

Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis

M Jun, C Foote, J Lv, B Neal, A Patel, SJ Nicholls… - The Lancet, 2010 - thelancet.com
Background Several clinical trials have reported inconsistent findings for the effect of fibrates
on cardiovascular risk. We undertook a systematic review and meta-analysis to investigate …

[图书][B] Brenner and Rector's the Kidney

ASL Yu, GM Chertow, VA Luyckx, PA Marsden… - 2020 - doctorlib.org
Sodium (Na+) is the principal osmole in extracellular fluid; as such, the total body content of
Na+ and Cl-, its primary anion, determine the extracellular fluid volume. Renal excretion or …

β-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment

LR Brunham, JK Kruit, TD Pape, JM Timmins… - Nature medicine, 2007 - nature.com
Type 2 diabetes is characterized by both peripheral insulin resistance and reduced insulin
secretion by β-cells. The reasons for β-cell dysfunction in this disease are incompletely …

An update on the lipid nephrotoxicity hypothesis

XZ Ruan, Z Varghese, JF Moorhead - Nature Reviews Nephrology, 2009 - nature.com
When the'lipid nephrotoxicity hypothesis' was proposed in 1982, it brought together several
disparate experimental findings in hyperlipidemia and renal disease to suggest that …

Cellular lipid metabolism and the role of lipids in progressive renal disease

CK Abrass - American journal of nephrology, 2004 - karger.com
Dyslipidemia contributes to the rate of progression of atherosclerosis and chronic kidney
disease. Also, chronic kidney disease leads to the development of secondary abnormalities …

Brothers in arms: ABCA1-and ABCG1-mediated cholesterol efflux as promising targets in cardiovascular disease treatment

SJCM Frambach, R de Haas, JAM Smeitink… - Pharmacological …, 2020 - Elsevier
Atherosclerosis is a leading cause of cardiovascular disease worldwide, and
hypercholesterolemia is a major risk factor. Preventive treatments mainly focus on the …

Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons

A Tenenbaum, M Motro, EZ Fisman - Cardiovascular diabetology, 2005 - Springer
There are three peroxisome proliferator-activated receptors (PPARs) subtypes which are
commonly designated PPAR alpha, PPAR gamma and PPAR beta/delta. PPAR alpha …

[HTML][HTML] New insights into renal lipid dysmetabolism in diabetic kidney disease

A Mitrofanova, G Burke, S Merscher… - World journal of …, 2021 - ncbi.nlm.nih.gov
Lipid dysmetabolism is one of the main features of diabetes mellitus and manifests by
dyslipidemia as well as the ectopic accumulation of lipids in various tissues and organs …

Effect of thiazolidinediones on albuminuria and proteinuria in diabetes: a meta-analysis

PA Sarafidis, PC Stafylas, PI Georgianos… - American Journal of …, 2010 - Elsevier
BACKGROUND: Because of the major clinical and economic burden of diabetic
nephropathy, new therapeutic tools to delay its progression are needed. Recent studies …